Trexquant Investment’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-107,431
| Closed | -$953K | – | 1758 |
|
|
2025
Q1 | $953K | Buy |
107,431
+15,055
| +16% | +$134K | 0.01% | 1107 |
|
|
2024
Q4 | $1.27M | Sell |
92,376
-42,569
| -32% | -$584K | 0.01% | 1018 |
|
|
2024
Q3 | $3.7M | Sell |
134,945
-75,802
| -36% | -$2.08M | 0.05% | 589 |
|
|
2024
Q2 | $5.15M | Buy |
+210,747
| New | +$5.15M | 0.08% | 397 |
|
|
2023
Q3 | – | Sell |
-27,604
| Closed | -$640K | – | 1702 |
|
|
2023
Q2 | $640K | Sell |
27,604
-31,300
| -53% | -$726K | 0.02% | 909 |
|
|
2023
Q1 | $1.37M | Buy |
58,904
+39,946
| +211% | +$928K | 0.04% | 598 |
|
|
2022
Q4 | $275K | Buy |
+18,958
| New | +$275K | 0.01% | 1132 |
|
|
2021
Q1 | – | Sell |
-12,810
| Closed | -$253K | – | 1346 |
|
|
2020
Q4 | $253K | Buy |
+12,810
| New | +$253K | 0.03% | 784 |
|
|
2017
Q2 | – | Sell |
-37,654
| Closed | -$723K | – | 1043 |
|
|
2017
Q1 | $723K | Buy |
37,654
+9,428
| +33% | +$181K | 0.09% | 384 |
|
|
2016
Q4 | $471K | Buy |
+28,226
| New | +$471K | 0.07% | 465 |
|
|
2016
Q3 | – | Sell |
-51,305
| Closed | -$1.57M | – | 898 |
|
|
2016
Q2 | $1.57M | Buy |
51,305
+31,621
| +161% | +$968K | 0.21% | 135 |
|
|
2016
Q1 | $737K | Buy |
+19,684
| New | +$737K | 0.09% | 393 |
|